- Demonstration of “Croquis” and Presentation of Lifting Effects Research Results at “IMCAS 2022”
- Global medical specialist spoke to share information on how Croquis is performed and research results
- Operated exhibition booth and pursued expanding partnerships with global companies

▲ Over 250 people watched the croquis procedure and clinical case report by Dr. Fredrik Berne, a cosmetic surgery specialist from Sweden, during IMCAS 2022, showing high levels of interest in croquis.

▲Samyang Holdings Biopharmaceuticals Division participated in the International Master Course on Aging Science (IMCAS) 2022 and promoted the excellence of its facelift thread brand Croquis.

Facelift thread brand “Croquis” by Samyang Holdings Biopharmaceuticals Division is accelerating its efforts to expand its global market. As suggested by the name, which originates from a drawing technique that quickly sketches the outline of a model, croquis promotes its ability to lift the facial contour quickly and naturally.

Samyang Holdings Biopharmaceuticals Division (Head: Lee Young-Joon) participated on the 14th in “IMCAS (International Master Course on Aging Science) 2022” held in Paris, France from June 3 to 5 local time to announce the safety and effectiveness of croquis while demonstrating the procedure. Celebrating its 24th anniversary, IMCAS is one of the world’s top 3 cosmetic surgery conferences where medical professionals from around the world gather to share the latest technologies and opinions. The event was held online last year due to COVID-19 but returned to the regular offline event this year as scheduled. Approximately 600 companies and more than 12,000 people attended this event; thus restoring pre-COVID-19 levels.

Samyang Holdings Biopharmaceuticals Division demonstrated the croquis procedure and presented the research results together with world-renowned medical professionals while operating exhibition booths to hold meetings with global companies to increase exports. On the 4th, which was the second day of the conference, Doctor Fredrik Berne, a cosmetic surgery specialist from Sweden, presented the clinical case of croquis on the theme of “lower jaw shape and eyebrow lifting effects of croquis.” During this lecture, following the effects of the front face procedure presented in the past, jaw line and eyebrow lifting effects were newly introduced, exhibiting precise procedure methods; thus drawing applause from over 250 people in the audience.

“We saw high interest in the croquis procedure and clinical cases of global medical professionals at this event. As this event restored pre-pandemic levels and it was held as a large offline event, we have become confident in responding to the demand of the cosmetic surgery market, which is expected to increase together with the reopening of economic activities following the endemic. In the future, we will conduct aggressive evidence-based marketing using clinical results, accelerate exports, and increase our influence in the global market,” a spokesperson for Croquis said.

Croquis, a facelift thread brand from Samyang Holdings Biopharmaceuticals Division, targeted the global market right from the launch, releasing global case studies and research results while proving its efficacy and safety to the world through data. The company signed sales contracts in 18 countries, including Japan and European countries, and it is also seeking marketing approval in the US and Australia.

Meanwhile, the Biopharmaceuticals Division gained trust from the global cosmetic surgery industry through reasonable, data-based marketing, earning its second-mover advantage. While the conventional aesthetic facelift thread brands emphasize changes before and after the procedure, the Biopharmaceuticals Division is currently conducting research with key opinion leaders to secure clinical evidence to ensure safe and effective facelift procedures.